Theo Roth is leading research over at the Stanford Blood Center in Palo Alto. He has welcomed 3 summer undergraduate interns and in addition has since acquired 2 full time Research Associate’s. The group at Hillview primarily works on gene editing in primary immune cells.

31 August 2022

Check out the lab’s recent publication in Cancer Cell titled “Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence”! The journal cover depicts an artistic representation of our team’s exciting CRISPR-based genome engineering work. You can see hands manipulating the human genome – meant to show the removal […]

12 July 2022

Check out this preview from Laura Snell in regards to the lab’s recent publication in Immunity!

11 July 2022

Madeline Layeghi has joined the Satpathy Lab as the Scientific Director in June of 2022. Previous to joining us, Madeline was with the Marson Lab at the Gladstone Institutes where she worked with Ralf Schmidt and Zach Steinhardt. Their paper on CRISPR activation and interference screens was published in Science in 2022. Madeline also worked […]

7 July 2022

The Cancer Research Institute awarded Ansu with the Lloyd J. Old STAR recognition in 2022. STAR stands for Scientists TAking Risks – a program which allows high-risk, high-reward research in the promising field of cancer immunotherapy. This award is given to scientists who prove to be trailblazers in the field, who propel and push the […]

The Satpathy Lab is proud to not only be part of the Stanford Medicine Department of Pathology, but also part of the Gladstone-UCSF Institute of Genomic Immunology. We had the pleasure of taking part in the Gladstone-UCSF Institute of Genomic Immunology’s retreat in June 2022 which was held at the Log Cabin in the Presidio, […]

13 June 2022

Congratulations to Julia for successfully defending her thesis! During her time in the lab as a graduate student in the Computer Science PhD program, Julia has led and contributed to numerous projects on T cell exhaustion, SARS-CoV-2 RNA-host protein interactions, and more. We wish Dr. Belk the best of luck as she starts her postdoc […]

15 March 2022

Congrats to Stefanie and Caleb on their respective reviews! Stefanie’s review on bystander T cells in cancer is out now in Nature Cancer. Caleb’s review on the use of single-cell genomic technologies in immunotherapy is out in Cancer Cell. Read their reviews here:Meier, Satpathy, and Wells. Bystander T cells in cancer immunology and therapy. Nature […]

23 February 2022

We are excited to be part of the Gladstone-UCSF Institute of Genomic Immunology and join the community of researchers in immunology, synthetic biology, human genetics, and CRISPR genome engineering to harness the human immune system for therapeutic benefit. Find out more about the Institute here: https://gladstone.org/science/genomic-immunology-institute

15 February 2022

Congratulations to Chris for receiving the Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship! The fellowship provides financial support and career training to the most promising young scientists in basic and tumor immunology, with the goal of contributing to cancer immunotherapy research. https://www.cancerresearch.org/en-us/scientists/fellowships-grants/post-doctoral-fellows

13 December 2021